When 20 μm LY294002 was used to treat NPC cells, the drug resistance curve shifted significantly to the left, indicating that LY294002 could significantly reverse the drug resistance induced by TMEM52B (Figure 8D). The gene discussed is TMEM52B; the disease is nasopharyngeal carcinoma.